vs
LSI INDUSTRIES INC（LYTS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是LSI INDUSTRIES INC的1.4倍（$197.9M vs $143.9M），REPLIGEN CORP净利率更高（6.7% vs 1.4%，领先5.3%），REPLIGEN CORP同比增速更快（13.6% vs -4.4%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 2.1%）
LSI Logic Corporation是一家总部位于加利福尼亚州圣克拉拉的美国公司，主营专用集成电路与电子设计自动化业务，设计并销售可加速数据中心、移动网络及客户端计算领域存储与网络性能的半导体和软件产品。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
LYTS vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$143.9M
营收增速更快
RGEN
高出18.0%
-4.4%
净利率更高
RGEN
高出5.3%
1.4%
两年增速更快
RGEN
近两年复合增速
2.1%
损益表 — Q1 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.9M | $197.9M |
| 净利润 | $2.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 1.4% | 6.7% |
| 营收同比 | -4.4% | 13.6% |
| 净利润同比 | -4.8% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LYTSRGEN
| Q3 26 | $143.9M | — | ||
| Q1 26 | $143.9M | — | ||
| Q4 25 | $147.0M | $197.9M | ||
| Q3 25 | $157.2M | $188.8M | ||
| Q2 25 | $155.1M | $182.4M | ||
| Q1 25 | $132.5M | $169.2M | ||
| Q4 24 | $147.7M | $174.1M | ||
| Q3 24 | $138.1M | $154.9M |
净利润LYTSRGEN
| Q3 26 | $2.0M | — | ||
| Q1 26 | $2.0M | — | ||
| Q4 25 | $6.3M | $13.3M | ||
| Q3 25 | $7.3M | $14.9M | ||
| Q2 25 | $8.2M | $14.9M | ||
| Q1 25 | $3.9M | $5.8M | ||
| Q4 24 | $5.6M | $-30.3M | ||
| Q3 24 | $6.7M | $-654.0K |
毛利率LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 25.5% | 52.5% | ||
| Q3 25 | 25.6% | 53.2% | ||
| Q2 25 | 26.1% | 50.0% | ||
| Q1 25 | 24.8% | 53.6% | ||
| Q4 24 | 23.6% | 26.1% | ||
| Q3 24 | 24.4% | 50.0% |
营业利润率LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 9.0% | ||
| Q3 25 | 7.0% | 8.9% | ||
| Q2 25 | 7.7% | 7.6% | ||
| Q1 25 | 4.7% | 3.9% | ||
| Q4 24 | 5.7% | -17.7% | ||
| Q3 24 | 6.6% | -5.1% |
净利率LYTSRGEN
| Q3 26 | 1.4% | — | ||
| Q1 26 | 1.4% | — | ||
| Q4 25 | 4.3% | 6.7% | ||
| Q3 25 | 4.6% | 7.9% | ||
| Q2 25 | 5.3% | 8.2% | ||
| Q1 25 | 2.9% | 3.4% | ||
| Q4 24 | 3.8% | -17.4% | ||
| Q3 24 | 4.8% | -0.4% |
每股收益（稀释后）LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $0.20 | $0.24 | ||
| Q3 25 | $0.23 | $0.26 | ||
| Q2 25 | $0.26 | $0.26 | ||
| Q1 25 | $0.13 | $0.10 | ||
| Q4 24 | $0.18 | $-0.55 | ||
| Q3 24 | $0.22 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $261.0M | $542.2M |
| 股东权益账面价值 | $352.8M | $2.1B |
| 总资产 | $800.5M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $6.4M | $767.6M | ||
| Q3 25 | $7.1M | $748.7M | ||
| Q2 25 | $3.5M | $708.9M | ||
| Q1 25 | $4.3M | $697.2M | ||
| Q4 24 | $4.7M | $757.4M | ||
| Q3 24 | $7.0M | $784.0M |
总债务LYTSRGEN
| Q3 26 | $261.0M | — | ||
| Q1 26 | $261.0M | — | ||
| Q4 25 | $27.9M | $542.2M | ||
| Q3 25 | $50.7M | $537.9M | ||
| Q2 25 | $48.6M | — | ||
| Q1 25 | $55.4M | — | ||
| Q4 24 | $38.2M | $525.6M | ||
| Q3 24 | $47.7M | — |
股东权益LYTSRGEN
| Q3 26 | $352.8M | — | ||
| Q1 26 | $352.8M | — | ||
| Q4 25 | $248.1M | $2.1B | ||
| Q3 25 | $241.3M | $2.1B | ||
| Q2 25 | $230.7M | $2.1B | ||
| Q1 25 | $221.7M | $2.0B | ||
| Q4 24 | $217.1M | $2.0B | ||
| Q3 24 | $211.2M | $2.0B |
总资产LYTSRGEN
| Q3 26 | $800.5M | — | ||
| Q1 26 | $800.5M | — | ||
| Q4 25 | $396.3M | $2.9B | ||
| Q3 25 | $404.9M | $2.9B | ||
| Q2 25 | $396.4M | $2.9B | ||
| Q1 25 | $384.6M | $2.9B | ||
| Q4 24 | $344.5M | $2.8B | ||
| Q3 24 | $349.5M | $2.8B |
负债/权益比LYTSRGEN
| Q3 26 | 0.74× | — | ||
| Q1 26 | 0.74× | — | ||
| Q4 25 | 0.11× | 0.26× | ||
| Q3 25 | 0.21× | 0.26× | ||
| Q2 25 | 0.21× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 0.18× | 0.27× | ||
| Q3 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $25.0M | $25.7M | ||
| Q3 25 | $676.0K | $48.1M | ||
| Q2 25 | $9.5M | $28.6M | ||
| Q1 25 | $6.9M | $15.0M | ||
| Q4 24 | $9.9M | $39.2M | ||
| Q3 24 | $11.8M | $49.3M |
自由现金流LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $23.3M | $17.6M | ||
| Q3 25 | $-291.0K | $43.4M | ||
| Q2 25 | $8.5M | $21.5M | ||
| Q1 25 | $6.2M | $11.4M | ||
| Q4 24 | $8.8M | $33.6M | ||
| Q3 24 | $11.1M | $42.3M |
自由现金流率LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 15.8% | 8.9% | ||
| Q3 25 | -0.2% | 23.0% | ||
| Q2 25 | 5.5% | 11.8% | ||
| Q1 25 | 4.7% | 6.8% | ||
| Q4 24 | 6.0% | 19.3% | ||
| Q3 24 | 8.0% | 27.3% |
资本支出强度LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | 0.6% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.7% | 3.2% | ||
| Q3 24 | 0.5% | 4.5% |
现金转化率LYTSRGEN
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 3.94× | 1.93× | ||
| Q3 25 | 0.09× | 3.23× | ||
| Q2 25 | 1.16× | 1.92× | ||
| Q1 25 | 1.77× | 2.57× | ||
| Q4 24 | 1.75× | — | ||
| Q3 24 | 1.77× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
